Rui Reis
(3B's Research Group/Univ. Minho, Portugal)

Rui L. Reis, PhD, DSc, Hon. Causa MD, Hon Causa PhD, FBSE, FTERM, member of NAE, FAIMBE, FEAMBES, is a Full Professor of Tissue Engineering, Regenerative Medicine, Biomaterials and Stem Cells at University of Minho (UMinho), Portugal. He is the Founding Director of the 3B’s Research Group and Dean/President of the I3Bs – Institute for Biomaterials, Biodegradables and Biomimetics at UMinho. He is also the CEO of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine and has been the Global President of the Tissue Engineering and Regenerative Medicine International Soc. (TERMIS). He is Associate Editor of PNAS-NEXUS and is in the Editorial Board of several other relevant journals. He co-founded several companies that raised important private investments. His work has been cited more than 98000 times and he is listed in the annual Highly Cited Researchers 2022 and 2023 list from Clarivate. He has been awarded many important international prizes.

Milica Radisic
(University of Toronto, Canada)

Dr. Milica Radisic is a Professor at the University of Toronto, Tier 1 Canada Research Chair in Organ-on-a-Chip Engineering and a Senior Scientist at the Toronto General Research Institute. She is also Director of the NSERC CREATE Training Program in Organ-on-a-Chip Engineering & Entrepreneurship and a co-lead for the Center for Research and Applications in Fluidic Technologies. She is a Fellow of the Royal Society of Canada-Academy of Science, Canadian Academy of Engineering, the American Institute for Medical & Biological Engineering, Tissue Engineering & Regenerative Medicine Society as well as Biomedical Engineering Society. She was a recipient of the MIT Technology Review Top 35 Under 35, Queen Elizabeth II Diamond Jubilee Medal, NSERC E.W.R Steacie Fellowship, YWCA Woman of Distinction Award, Killam Fellowship, Acta Biomaterialia Silver Medal, and Humboldt Research Award to name a few. Her research focuses on organ-on-a-chip engineering and development of new biomaterials that promote healing and attenuate scarring. She developed new methods to mature iPSC derived cardiac tissues using electrical stimulation. She is an Executive Editor for ACS Biomaterials Science & Engineering, Senior Consulting Editor for the Journal of Molecular and Cellular Cardiology, a reviewing editor for eLife and a member of the editorial board of another 8 journals. She served on the Board of Directors for Ontario Society of Professional Engineers, Canadian Biomaterials Society and McMaster University Alumni Association. She organized Keystone, EMBO and ECI conferences and numerous sessions at TERMIS and BMES meetings. She served as a Scientific Officer for the Canadian Institutes of Health Research and member of review panels for CIHR, NIH and Israel Ministry of Education. She is the Chair of Investment Committee for Serbia Innovation Fund. She is a co-founder of two companies TARA Biosystems (acquired by Valo Health), that uses human engineered heart tissues in drug development and safety testing, and Quthero that advances regenerative hydrogels. Her work has been presented in over 260 publications, garnering over 20,000 citations with an h-index of 71. Her publications appeared in Cell, Nature Materials, Nature Methods, Nature Protocols, Nature Communications, PNAS etc.

Changyou Gao
(Zhejiang University, China)

Changyou Gao graduated from Department of Chemistry, Jilin University to get his Bachelor degree (1990), Master degree (1993) and Ph.D of Polymer Chemistry and Physics (1996). From 1996 to 1998, he worked in Department of Polymer Science and Engineering of Zhejiang University as a postdoctor fellowship. He was a DAAD and visiting scholar in Germany (1999). He is a Cheung Kong Scholar of Ministry of Education of China, a winner for the National Science Fund for Distinguished Young Scholars of China, a fellow of the international federation of biomaterial science and engineering societies, the American Institute of Medicinal and Biological Engineering, Royal Society of Chemistry, and Chinese Society of Biomaterials. He is now serving as an associate president of Chinese Society of Biomaterials, and an associate editor of Biomaterials Advances and Progress in Materials Science. His research interests include self-adaptive biomaterials, immuno-modulation biomaterials, anti-bacterial biomaterials and their applications in tissue repair and regeneration. He has published more than 500 papers with an H-index of 78.

Laura Poole-Warren
(The University of New South Wales, Australia)

Laura is a Professor in Biomedical Engineering at UNSW and leads a research group focussed on design and development of novel materials for neural electrodes and other soft-tissue interfaces, and on 3D engineered neural tissue models. A key theme of her work is on understanding material and device compatibility with cells and tissues. Throughout her career, she has worked across academia, industry, and government. She was a research professor at the New Jersey Centre for Biomaterials based at Rutgers University in the USA and a preclinical scientist in the biomedical industry working on development of wound dressings and embolic agents for cancer treatment from 1999 to 2001. She also served from 2003 to 2013 as a member of the Australian Government Therapeutic Goods Administration statutory expert committee on the safety of medical devices. Between 2005 and 2018, Laura held various leadership appointments at UNSW as Pro Vice-Chancellor, and Dean of Graduate Research, as well as being the Australian representative on the International Union of Societies of Biomaterials Science and Engineering. She was awarded honours in January 2020 as a Member of the Order of Australia (AM) for service to Biomedical Engineering and education, is a Fellow of three academies, FTSE, FAIMBE and FBSE and the Royal Society of NSW

Bikramjit Basu
(Indian Institute of Science, Bangalore, India)

Dr. Bikramjit Basu is a Professor at the Indian Institute of Science, Bangalore, India, since 2011 and earlier served on the faculty of the Indian Institute of Technology Kanpur (2001-2011). He has been pursuing research at the confluence of Materials Science, Additive Manufacturing, Biological Science, and Medicine, to address many unanswered questions related to regenerative engineering and reconstructive surgeries. His research group has effectively applied the principles and tools of these disciplines to develop next-generation implants and bioengineering solutions to address unmet clinical needs for musculoskeletal, dental, and neurosurgical applications; thereby impacting human healthcare. His research group has developed technologies related to the manufacturing of bioceramics, acetabular liners, customized bone flaps for cranioplasty surgeries, dental implants and variants of hydrogels. These technologies are transferred to multinational corporates or start-ups, and many of the products, after regulatory clearances, are currently used for patient care in India.
A Chartered Engineer of the UK, he has the unique distinction of being the only ceramic scientist from India to get elected to all the major international societies and academies, including the World Academy of Ceramics (2024), the European Ceramic Society (2023), the American Ceramic Society (2019). In India, he is the only engineering scientist to get elected as a Fellow of all the National Academies of Engineering, Science and Medicine, including the Indian National Science Academy (2021), Indian Academy of Sciences (2020), American Ceramic Society (2019), National Academy of Medical Sciences (2017), Indian National Academy of Engineering (2015), and National Academy of Sciences, India (2013). Internationally, he is an elected fellow of the International Union of Societies for Biomaterials Science and Engineering (2020), International Academy of Medical and Biological Engineering (2017) and the American Institute of Medical and Biological Engineering (2015). He is a recipient of India’s most prestigious Science and Technology award, Shanti Swarup Bhatnagar Prize (2013) from the Prime Minister of India; and globally competent awards, like Humboldt Research Award from the Alexander von Humboldt foundation (2022), and International Richard Brook Award from the European Ceramic Society (2022). He is currently serving on many advisory panels of the national institutes, European university and federal funding agencies as well as major multinational corporates. As the current President of the Society for Biomaterials and Artificial Organs India (1000+ members across India, US and Europe) and in his leadership roles as the Chair of Bioceramics Division and other principal committees of the American Ceramic Society (ACerS), he has brought transformative changes to significantly enhance international visibility of the biomaterials programs in different countries, while inspiring several hundreds of young researchers in Bioceramics area across the world. Such activities together with his roles as the lead investigator in several multi-institutional network programs including multicentric clinical studies enabled creating a vibrant translational ecosystem, to bring together key stakeholders (industry professionals and clinicians) on the innovation platform in India.

Jurica Bauer
(Maastricht University, Netherlands)

Dr. Jurica Bauer graduated in chemistry from the University of Zagreb, Croatia, where he developed a passion for research and teaching. Having worked as medicinal chemist at GlaxoSmithKline for a few years, he moved to The Netherlands to pursue a PhD degree in the field of molecular motors and machines with Professor Feringa at the University of Groningen. As a postdoctoral researcher in the group of Professor Broer at the Eindhoven University of Technology and in collaboration with Philips, he developed a smart liquid-crystalline polymer coating for LEDs to fine-tune the properties of emitted light. In 2014 he was appointed Lecturer in Chemistry at the Inholland University of Applied Sciences in Amsterdam where he developed a new Polymer Chemistry minor and acted as graduation and internationalization coordinator. In 2020 he joined the MERLN Institute at the Maastricht University as Assistant Professor of Education to coordinate the design and development of a new undergraduate study program in the field of Regenerative Medicine and Technology. He is also involved in ongoing teaching and research activities within the institute. His interests include innovation and research in STEM education and scientific research in the field of smart, and especially photoresponsive, nanobiomaterials for medicinal applications.

Young Jung No
(The University of Sydney, Australia)

Dr Young No is a biomaterials engineer, Lecturer (US: Assistant Professor) and Deputy Head of School (Education) at the School of Biomedical Engineering at the University of Sydney, and also served as acting Associate Dean (Learning and Teaching) at the Faculty of Engineering in early 2023. Dr No was also awarded “40 under 40 Most Influential Asian-Australian for 2022” by the Asian-Australian Leadership Summit for his leadership in biomedical engineering programs at the University of Sydney, shaping the curriculum to be the most comprehensive in the southern hemisphere in terms of topics and areas covered to match the rapidly rising importance and relevance of biomedical engineering in the modern-day technological setting. His innovative and engaging teaching practices in his classes have been well-recognised, with multiple commendations received for his courses, teaching awards, and being featured in university videos for World Teachers’ Day in 2023. Dr No has also led and contributed significantly to biomedical engineering outreach, resulting in significantly increased interest in biomedical engineering amongst prospective students and subsequently increased number of students pursuing biomedical engineering at the University of Sydney for their professional careers.

Dr No’s area of research is in the engineering and characterising novel synthetic bioactive materials for musculoskeletal applications, with primary focus on developing novel cements and ceramic composites. He has published 17 peer-reviewed journal articles, with all publications in journals ranked in the top 30% (Scimago Journal Rank) in the fields of materials science and biomedical engineering, including in high impact journals in the field, and has two published patents as primary co-inventor. His research on the synthetic biomaterials has been the subject of multiple successful grant applications, including the Australian Research Council Linkage Grant as well as other grants including the University of Sydney Commercial Development and Industry Partnership Fund, Australia–Germany Joint Research Co-operation Scheme (DAAD), and Harvard Mobility Scheme. YJN’s work has also been recognised for impact and won presentation awards in conferences including the Australia New Zealand Orthopaedic Research Society (ANZORS), and TERMIS-AP.

Johnna S. Temenoff
(Georgia Tech and Emory University, USA)

Dr. Johnna S. Temenoff is the Carol Ann and David D. Flanagan Professor the Coulter Department of Biomedical Engineering at Georgia Tech/Emory University. She is also currently the Director of the NSF Engineering Research Center in Cell Manufacturing Technologies (CMaT) and the Director of the Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M). Scientifically, Dr. Temenoff is interested in scaling culture of therapeutic cells and tailoring the molecular interactions between glycosaminoglycans and proteins/cells for use in regenerative medicine applications. Her laboratory focuses primarily on promoting repair after injuries to the tissues of the shoulder, including cartilage, tendon, and muscle.

Jurica Bauer
(Maastricht University, Netherlands)

Dr. Jurica Bauer graduated in chemistry from the University of Zagreb, Croatia, where he developed a passion for research and teaching. Having worked as medicinal chemist at GlaxoSmithKline for a few years, he moved to The Netherlands to pursue a PhD degree in the field of molecular motors and machines with Professor Feringa at the University of Groningen. As a postdoctoral researcher in the group of Professor Broer at the Eindhoven University of Technology and in collaboration with Philips, he developed a smart liquid-crystalline polymer coating for LEDs to fine-tune the properties of emitted light. In 2014 he was appointed Lecturer in Chemistry at the Inholland University of Applied Sciences in Amsterdam where he developed a new Polymer Chemistry minor and acted as graduation and internationalization coordinator. In 2020 he joined the MERLN Institute at the Maastricht University as Assistant Professor of Education to coordinate the design and development of a new undergraduate study program in the field of Regenerative Medicine and Technology. He is also involved in ongoing teaching and research activities within the institute. His interests include innovation and research in STEM education and scientific research in the field of smart, and especially photoresponsive, nanobiomaterials for medicinal applications.

Young Jung No
(The University of Sydney, Australia)

Dr Young No is a biomaterials engineer, Lecturer (US: Assistant Professor) and Deputy Head of School (Education) at the School of Biomedical Engineering at the University of Sydney, and also served as acting Associate Dean (Learning and Teaching) at the Faculty of Engineering in early 2023. Dr No was also awarded “40 under 40 Most Influential Asian-Australian for 2022” by the Asian-Australian Leadership Summit for his leadership in biomedical engineering programs at the University of Sydney, shaping the curriculum to be the most comprehensive in the southern hemisphere in terms of topics and areas covered to match the rapidly rising importance and relevance of biomedical engineering in the modern-day technological setting. His innovative and engaging teaching practices in his classes have been well-recognised, with multiple commendations received for his courses, teaching awards, and being featured in university videos for World Teachers’ Day in 2023. Dr No has also led and contributed significantly to biomedical engineering outreach, resulting in significantly increased interest in biomedical engineering amongst prospective students and subsequently increased number of students pursuing biomedical engineering at the University of Sydney for their professional careers.

Dr No’s area of research is in the engineering and characterising novel synthetic bioactive materials for musculoskeletal applications, with primary focus on developing novel cements and ceramic composites. He has published 17 peer-reviewed journal articles, with all publications in journals ranked in the top 30% (Scimago Journal Rank) in the fields of materials science and biomedical engineering, including in high impact journals in the field, and has two published patents as primary co-inventor. His research on the synthetic biomaterials has been the subject of multiple successful grant applications, including the Australian Research Council Linkage Grant as well as other grants including the University of Sydney Commercial Development and Industry Partnership Fund, Australia–Germany Joint Research Co-operation Scheme (DAAD), and Harvard Mobility Scheme. YJN’s work has also been recognised for impact and won presentation awards in conferences including the Australia New Zealand Orthopaedic Research Society (ANZORS), and TERMIS-AP.

Jeong-Kee Yoon
(Chung-Ang University, Korea, Republic of)

Dr. Jeong-Kee Yoon is an associate professor in the Department of Systems Biotechnology at Chung-Ang University, Republic of Korea. He received his Ph.D. degree from Seoul National University, Republic of Korea in 2017, and worked as a postdoctoral researcher at Georgia Institute of Technology until 2021. His research interests are at the interface of regenerative medicine and biomedical engineering, primarily focused on vascular engineering using stem cells, engineered exosomes, and 3D cell culture methods for tissue regeneration and disease modeling. He has published 51 peer-reviewed articles, and is a co-inventor on two registered patents. In terms of education, he teaches Organic Chemistry, Biomaterials, and Biomedical Engineering to undergraduates of non-engineering majors, and Tissue Engineering and Regenerative Medicine to graduate students. He has been selected twice (in 2022 and 2023) as a Teacher of Excellence at Chung-Ang University based on surveys completed by 70-80 students per class.

Hyuk Sang Yoo
(Kangwon National University, Korea, Republic of)

He received a B.S. degree (1996), a M.S. degree (1998), and a Ph.D. degree (2002, Advisor: Professor Tae Gwan Park) at Department of Biological Sciences, Korea Advanced Institute of Science and Technology. After a post-doctoral fellow at Department of Biomedical Engineering, the Johns Hopkins University (2004, Advisor: Professor Kam W. Leong), he joined the Kangwon National University as an assistant professor (2005). He is now a tenured professor of Biomedical Materials Engineering. He was also a visiting scholar for the Johns Hopkins University (2005) and the Northwestern University (2010). His research is focused on nano-biomaterials for drug delivery and tissue engineering employing multifunctional nanofibers and nanoparticles.

Katja Schenke-Layland
(Eberhard Karls University Tubingen, Germany)

Katja Schenke-Layland is the Professor of Medical Technologies and Regenerative Medicine at the Medical Faculty of the University Tübingen (MFT). She is the Director of the NMI Natural and Medical Sciences Institute in Reutlingen, the CEO of the NMI-TT GmbH, and the Study Dean of Medical Technologies at the University of Tübingen. Katja is currently the Co-Editor-In-Chief of Tissue Engineering Part B (Mary Ann Liebert) and Executive Editor of Advanced Drug Delivery Reviews (Elsevier), as well as on several editorial boards such as Matrix Biology (Elsevier), Current Opinion in Biomedical Engineering (Elsevier), and Journal of 3D Printing in Medicine (Future Medicine). Katja is a fellow/ board member of the German National Academy of Science and Engineering (acatech), the German Central Ethics Committee for Stem Cell Research (ZES), International and German Societies of Matrix Biology, and the European Alliance for Medical and Biological Engineering and Science (EAMBES). She has published more than 190 peer-reviewed articles, has an h-index of 51 (Scopus), and has been granted 4 patents.

Kent Leach
(University of California Davis, USA)

J. Kent Leach is the Lawrence J. Ellison Endowed Professor of Musculoskeletal Research and Vice Chair of Research in the Department of Orthopaedic Surgery and Professor of Biomedical Engineering at the University of California, Davis. His research interests are focused on developing cell-instructive biomaterials for tissue engineering of replacement tissues and cultivated meat, applying transport principles for growth of engineered tissues and modeling cancer, and translation from the bench to the clinic. He is the Editor-in-Chief of the Journal of Biomedical Materials Research Part A, the official journal of the Society for Biomaterials (SFB). He was inducted into the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE) in 2017 and as a Fellow of the Biomedical Engineering Society in 2018. He is the Program Director of one of eight NIH-funded predoctoral training grants focused on musculoskeletal health nationally. He has received multiple teaching and mentorship awards at UC Davis, and he holds various leadership roles in his scientific communities including the Board of Directors of BMES and within the Orthopaedic Research Society (ORS).

Katja Schenke-Layland
(Eberhard Karls University Tubingen, Germany)

Katja Schenke-Layland is the Professor of Medical Technologies and Regenerative Medicine at the Medical Faculty of the University Tübingen (MFT). She is the Director of the NMI Natural and Medical Sciences Institute in Reutlingen, the CEO of the NMI-TT GmbH, and the Study Dean of Medical Technologies at the University of Tübingen. Katja is currently the Co-Editor-In-Chief of Tissue Engineering Part B (Mary Ann Liebert) and Executive Editor of Advanced Drug Delivery Reviews (Elsevier), as well as on several editorial boards such as Matrix Biology (Elsevier), Current Opinion in Biomedical Engineering (Elsevier), and Journal of 3D Printing in Medicine (Future Medicine). Katja is a fellow/ board member of the German National Academy of Science and Engineering (acatech), the German Central Ethics Committee for Stem Cell Research (ZES), International and German Societies of Matrix Biology, and the European Alliance for Medical and Biological Engineering and Science (EAMBES). She has published more than 190 peer-reviewed articles, has an h-index of 51 (Scopus), and has been granted 4 patents.

Fan Yang
(Stanford University School of Medicine, USA)

Fan Yang is an Associate Professor with tenure at Stanford University with joint appointments in the Departments of Bioengineering and Orthopaedic Surgery, and Director of Stanford Stem Cells and Biomaterials Engineering Laboratory. Her research seeks to develop hydrogels with unique design at micro- and nano- scales to modulate stem cell differentiation, tissue regeneration and immunomodulation, with applications focus on musculoskeletal diseases. Her lab also harnesses biomaterials to create 3D cancer models with in vivo-mimicking phenotype and drug responses. Such 3D models could enable discovering novel druggable targets that would otherwise be missed using conventional 2D culture, and enable high-throughput drug screening with reduced cost and time than animal models. Prior to joining Stanford, Dr. Yang received her Ph.D. in Biomedical Engineering from Johns Hopkins University, and then completed a postdoctoral fellowship at MIT under Prof. Robert Langer. In recognition of her innovation, she has been recognized by numerous awards including Fellow of American Institute for Medical and Biological Engineering, MIT TR35 Global list honoree, National Science Foundation CAREER award, Young Investigator Award from Society for Biomaterials, Biomaterials Science Lectureship Award, Young Investigator award from Alliance for Cancer and Gene Therapy, Ellen Weaver Award by the Association for Women in Science, Baxter Faculty Scholar Award, the McCormick Faculty Award, Stanford Asian American Faculty Award, and the Basil O’Connor Starter Scholar Research Award.

Byeongmoon Jeong
(Ewha Womans University, Korea, Republic of)

Byeongmoon Jeong received his B.S. (1987) in the Department of Chemistry from Seoul National University, M.S (1989) from KAIST, and his Ph.D. (1999) in the Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah. He worked at the Pacific Northwest National Laboratory, USA as a senior research scientist before joining Ewha Womans University in 2002. He has authored 150 international peer-reviewed papers and patents on stimuli-sensitive polymers; particularly related to biodegradable thermogels. His publications have been cited 17,000 times during the last decade. He received an Achievement Award in the Polymer Division of Korean Chemical Society (2010), Hanwha Polymer Award from Polymer Society of Korea (2021), Osstem Implant Biomaterials Grand Prize from Korean Society for Biomaterials (KSBM) (2022). His research concentrates on stimuli-sensitive hydrogels and their applications for drug delivery and tissue engineering. He is also serving as vice president of KSBM and editor in cheif of Biomaterials Research, an official journal of KSBM.

James Moon
(University of Michigan, Ann Arbor, USA)

Dr. James Moon is John Gideon Searle Professor in the Department of Pharmaceutical Sciences, Biomedical Engineering, and Chemical Engineering at the University of Michigan, Ann Arbor. His interdisciplinary research program aims to develop novel biomaterials-based strategies to advance fundamental understanding of the immune system, with the ultimate goal of improving patients’ lives with effective vaccines and immunotherapies. Dr. Moon has published over 120 research articles, including those published in Nature Materials, Nature Medicine, Nature Nanotechnology, Nature Biomedical Engineering, Nature Reviews Materials, and Science Translational Medicine. He has over 20 pending/approved U.S. and international patent applications, and his novel nano-vaccine delivery technologies have led to 3 new start-up companies (EVOQ Therapeutics, Saros Therapeutics, and Elicio Therapeutics). Dr. Moon is a fellow of BMES, AIBME, and CRS, and his contributions to the field has been recognized with numerous awards, including NSF CAREER Award and Samyang CRS Award. Dr. Moon received his bachelor’s degree from the University of California, Berkeley (2002), and his Ph.D. from Rice University (2008), and he completed his postdoctoral training at MIT. He joined the faculty of the University of Michigan in 2012.

James Wabby
(Regulatory Affairs (CoE), AbbVie, Inc, USA)

James is responsible for leading global regulatory affairs for AbbVie’s device and medicinal/device delivery portfolio providing the vision for the future of device at AbbVie and in the broader industry.
James has 22 years of experience in increasing regulatory compliance and regulatory affairs responsibilities within the GxP regulated environment pertaining to Medical Devices, Medicinal Delivery Platforms, Companion Diagnostics, Digital Medicine, and Combination Product areas. He regularly provides AbbVie therapeutic franchise units regulatory counsel and strategy to all aspects within the quality management system and regulatory affairs.
James is an internationally recognized leader as he is a member of various regulatory/quality work groups and is a speaker and keynote at various regulatory symposia. In addition, he is the Chair of the DIA Combination Products Committee, Chair of the ISPE Combination Products (CoP), and a moderator for various global regulatory panel discussions.

James holds a BSc. in Biology from Duquesne University, MHMS in Health Law and Policy from Duquesne University, Certificate in Health Law and Life Science Regulatory Compliance from Seton Hall University Law School - Center for Health & Pharmaceutical Law, and Certificate, RAPS Executive Development Program from Northwestern University - Kellogg School of Management.

Shelly Sakiyama-Elbert
(University of Washington, USA)

Shelly Sakiyama-Elbert, Ph.D. is the Vice Dean for Research and Graduate Education in the University of Washington School of Medicine and Professor of Bioengineering. She earned a S.B. in chemical engineering and biology from Massachusetts Institute of Technology, and a M.S. and Ph.D. from California Institute of Technology. She joined the faculty at Washington University in Biomedical Engineering in 2000 as an Assistant Professor, where she advanced to the position of the Joseph and Florence Farrow Professor of Biomedical Engineering and Vice Dean for Research in the School of Engineering. She served as Department Chair and Professor of Biomedical Engineering at the University of Texas at Austin from 2016- 2022.
Her research program focuses on developing biomaterials for drug delivery and cell transplantation for the treatment of peripheral nerve and spinal cord injury. She was Co-Director of the Center of Regenerative Medicine, as well as a member of the Institute of Materials Science and Engineering at Washington University. Her honors include Senior Scientist Award -TERMIS AM (2023), Fellow of the National Academy of Inventors (2017), Society for Biomaterials Clemson Award for Basic Research (2017), Outstanding Faculty Mentor from the WU Graduate Student Senate (2015), WU Distinguished Faculty Award (2013), and WU Dean’s Award for Excellence in Advising and Mentoring (2008). She was elected Fellow of the International College of Fellows in Biomaterials Science and Engineering in 2016, the American Association for the Advancement of Science (AAAS) in 2015, the Biomedical Engineering Society (BMES) in 2013, and the and the American Institute for Medical and Biological Engineering (AIMBE) in 2011.

Hala Zreiqat
(University of Sydney, Australia)

Hala Zreiqat, is a Payne-Scott Professor of biomedical engineering at The University of Sydney. The focus of her lab is on engineering functional synthetic biomaterials for use in regenerative medicine using cutting-edge materials, biological and nano techniques, and novel 3D-printing technologies.

Prof. Zreiqat’s contribution to regenerative medicine and orthopaedic research has led to a number of national and international awards, including being named a Member of the Order of Australia (2019), 2021-2022 Fulbright Senior Scholar; Laureate for the TAKREEM Foundation 2022 “Scientific & Technological Achievement”; the 2018 New South Wales Premier’s Woman of the Year, the King Abdullah II Order of Distinction of the Second Class (2018), Radcliffe Fellow at Harvard University (2016-2017); Eureka Prize winner for Innovative Use of Technology (2019); and University of Sydney Payne-Scott Professorial Distinction (2019). She is also a Fellow of the Australian Academy of Sciences (2021); the Australian Academy of Technology & Engineering (2020), the International Association of Advanced Materials (2022), the Royal Society of New South Wales (2019); Australian Academy of Health and Medical Sciences (2019), and the International Orthopaedic Research Society (2019). She is the past president of the Australian & New Zealand Orthopaedic Research Society. She was the Director of the Australian Research Council Training Centre for Innovative BioEngineering (2017-2022) and a National Health and Medical Research Council Senior Research Fellow (2006-2020). She is the Chair of the Council for Australian-Arab Relations (CAAR) (2020-2023); an Associate of the John A. Paulson School of Engineering and Applied Sciences at Harvard University and an Honorary Professor at Shanghai Jiao Tong University.

Prof. Zreiqat has authored over 180 peer-reviewed publications with over 10,000 citations. Her research in the field of musculoskeletal disorders and biomaterials research has led to four awarded and four provisional patents and more than $20.5M in competitive funding, including major grants from the National Health and Medical Research Council, Australian Research Council and the New South Wales Medical Devices Fund.
As well as her pioneering work in biomaterials development, Prof. Zreiqat is committed to improving opportunities for women and young scientists around the world. She is the founder and Chair of the BIOTech Futures, a science and engineering mentorship program for high school students.

Sung Yun Yang
(Chungnam National University, Korea, Republic of)

Sung Yun Yang received her B.S and M.S. from Ewha Womans University in 1991 and 1993, respectively. After serving in the Chemistry division at KRICT and KIST, in 1995 moved to USA for her doctoral degree in Polymer Chemistry and Engineering at Polytechnic University, New York University currently. In August of 2000, she moved to MIT as a postdoctoral researcher in the Department of Materials Science and Engineering. She worked in a biotech company for a year and returned to Korea in 2004 starting her professorship at Chungnam National University. Since 2004 she has been with CNU, is now a professor of Organic Materials Engineering. Along with her research and academic activity, she also served as a vice-president of the Center for Women in Science, Engineering and Technology to promote educational opportunity for woman engineers. Prof. Yang’s research interests include functional nanomaterials for energy, environmental sustainability, and biomedical application.

Maria Chatzinikolaidou
(Foundation for Research and Technology Hellas (FORTH) Institute of Electronic Structure and Laser 100, Greece)

Dr. Maria Chatzinikolaidou, FBSE, FTERM, is an Associate Professor of Biomaterials in Bioengineering and Head of the Laboratory for Biomaterials in Tissue Engineering at the Department of Materials Science and Technology at the University of Crete (https://www.materials.uoc.gr/el/general/personnel/mchatzin.html), and affiliated faculty member at Foundation for Research and Technology – Hellas (FORTH). Her research interests focus on the development of biomaterials and scaffolds for tissue engineering applications including bone, dental, cardiovascular, and the validation of their in vitro and in vivo biocompatibility, functionality and biomechanical characteristics.
Dr. Chatzinikolaidou is actively involved in several competitive national and international projects, is author of >90 publications in international peer-reviewed journals, 4 book chapters, >180 peer-reviewed conference abstracts, and inventor of 4 patents on osteoinductive implants. She was elected member of the Executive Board of the Hellenic Society for Biomaterials and served as vice president in the terms 2015-2018 and 2022-now. She served as chair of the 28th Conference of the European Society for Biomaterials (ESB 2017) held in Athens, and program chair of the TERMIS-EU 2019 conference held in Rhodes in Greece. She is a Fellow in Biomaterials Science and Engineering (FBSE, elected 2020) of the International Union of Societies for Biomaterials Science and Engineering (IUS-BSE) and International Fellow of Tissue Engineering and Regenerative Medicine (FTERM, elected 2023). Since 2022 she is member of the Nomination Committee of Tissue Engineering and Regenerative Medicine International Society (TERMIS) EU chapter. She is an editorial board member in Tissue Engineering, Frontiers in Bioengineering and Biotechnology, Regenerative Biomaterials, Frontiers in Bioengineering and Biotechnology, Journal of Materials Science Materials in Medicine etc. She teaches lectures on Biomaterials, Cell Biology and Biochemistry, and Tissue Engineering in undergraduate and graduate courses at the University of Crete and other Universities in Grece, and is currently supervisor of four PhD candidates and three Master’s students.

Sung-Tae Kim
(Seoul national university School of Dentistry, Korea, Republic of)

Dentist, Periodontist, Prosthodontist, Tenured professor in Seoul National University School of Dentistry and Seoul National University Dental Hospital

Seong-Ok Na
(GENOSS, Korea, Republic of)

I work as a researcher at the R&D center of Genoss, a medical device manufacturing company.
While in charge of developing implantable medical devices, she led and participated in several projects for industrialization of biocompatible medical devices.

Paul Delrot
(Readily3D, Switzerland)

Paul co-invented the volumetric bioprinting technology at the end of his PhD studies at EPFL in 2017. After transferring what was a lab experiment into a standalone and user-friendly 3D printer, Paul co-founded Readily3D in 2020. Since then, Paul has focused on demonstrating the wide range of applications enabled by volumetric bioprinting while leading product development at Readily3D.

Terance Hart
(Maverick Biosciences, United Kingdom)

Dr Hart worked for over 30 years in Pharmaceutical Research for global companies such as Sanofi-Genzyme and Novartis as well as in many different Biotech companies, where he led teams in their discovery of new pharmaceuticals.

During the last 14 years he was for 10 years Chief Scientific Officer for Geistlich Pharma in Switzerland, where the R&D team brought through important, innovative collagen based products to the dental and tissue regeneration market, including Mucograft, Fibro-Gide and Derma-Gide. Currently he is a Scientific Advisor for Maverick Bioscience and a member of their Scientific Advisory Board.